Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
11 Dec 2020
Historique:
received: 22 11 2020
revised: 07 12 2020
accepted: 08 12 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 24 4 2021
Statut: epublish

Résumé

Spices, i.e., curcumin, ginger, saffron, and cinnamon, have a thousand-year history of medicinal use in Asia. Modern medicine has begun to explore their therapeutic properties during the last few decades. We aimed to perform a systematic literature review (SLR) of randomized controlled trials (RCTs) assessing the effect of spice supplementation on symptoms and disease activity in patients with chronic inflammatory rheumatic diseases (rheumatoid arthritis (RA), spondylarthritis, or psoriatic arthritis). An SLR of RCTs, reviews, and meta-analyses was performed, searching for articles in MEDLINE/PubMed. Abstracts from international rheumatology and nutrition congresses (2017-2020) were also scrutinized. The risk of bias of the selected studies was evaluated using the Cochrane Collaboration's tool and the Jadad scale. Altogether, six studies, assessing the use of spice supplementation only in RA patients, were included: one on garlic supplementation, two on curcumin, one on ginger, one on cinnamon, and one on saffron supplementation. Garlic, ginger, cinnamon, or saffron supplementation was associated with a decrease in RA clinical activity. However, several points limit the external validity of these studies. No conclusion on the impact of curcumin supplementation on RA activity could be drawn due to low-quality studies. Garlic, ginger, cinnamon, and saffron supplementation could have a beneficial effect on RA activity, but the risk of bias of these studies is difficult to assess and data are too limited to recommend them in daily practice.

Sections du résumé

BACKGROUND BACKGROUND
Spices, i.e., curcumin, ginger, saffron, and cinnamon, have a thousand-year history of medicinal use in Asia. Modern medicine has begun to explore their therapeutic properties during the last few decades. We aimed to perform a systematic literature review (SLR) of randomized controlled trials (RCTs) assessing the effect of spice supplementation on symptoms and disease activity in patients with chronic inflammatory rheumatic diseases (rheumatoid arthritis (RA), spondylarthritis, or psoriatic arthritis).
METHODS METHODS
An SLR of RCTs, reviews, and meta-analyses was performed, searching for articles in MEDLINE/PubMed. Abstracts from international rheumatology and nutrition congresses (2017-2020) were also scrutinized. The risk of bias of the selected studies was evaluated using the Cochrane Collaboration's tool and the Jadad scale.
RESULTS RESULTS
Altogether, six studies, assessing the use of spice supplementation only in RA patients, were included: one on garlic supplementation, two on curcumin, one on ginger, one on cinnamon, and one on saffron supplementation. Garlic, ginger, cinnamon, or saffron supplementation was associated with a decrease in RA clinical activity. However, several points limit the external validity of these studies. No conclusion on the impact of curcumin supplementation on RA activity could be drawn due to low-quality studies.
CONCLUSIONS CONCLUSIONS
Garlic, ginger, cinnamon, and saffron supplementation could have a beneficial effect on RA activity, but the risk of bias of these studies is difficult to assess and data are too limited to recommend them in daily practice.

Identifiants

pubmed: 33322318
pii: nu12123800
doi: 10.3390/nu12123800
pmc: PMC7764619
pii:
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nutrients. 2020 Jan 06;12(1):
pubmed: 31935866
Biochem Pharmacol. 2006 May 14;71(10):1397-421
pubmed: 16563357
Food Chem Toxicol. 2008 Feb;46(2):409-20
pubmed: 17950516
Pharmacology. 1994 Nov;49(5):314-8
pubmed: 7862743
Phytother Res. 2020 Nov;34(11):2953-2962
pubmed: 32478922
J Med Food. 2010 Feb;13(1):156-62
pubmed: 20136450
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Biotechnol Adv. 2020 Jan - Feb;38:107343
pubmed: 30716389
Phytother Res. 2020 Jul;34(7):1650-1658
pubmed: 32048365
Curr Opin Rheumatol. 2019 Sep;31(5):517-524
pubmed: 31268867
J Med Food. 2017 Oct;20(10):1022-1030
pubmed: 28850308
Joint Bone Spine. 2019 Mar;86(2):135-150
pubmed: 30315988
BMC Pharmacol. 2002 Mar 15;2:7
pubmed: 11914135
J Am Coll Nutr. 2018 May 3;:1-6
pubmed: 29722610
PLoS One. 2013 Sep 16;8(9):e73877
pubmed: 24066081
J AOAC Int. 2019 Mar 1;102(2):395-411
pubmed: 30651162
Mol Nutr Food Res. 2013 Nov;57(11):2049-60
pubmed: 23766070
BMC Complement Med Ther. 2020 Nov 9;20(1):333
pubmed: 33167948
Curr Opin Pharmacol. 2007 Jun;7(3):344-51
pubmed: 17475558
Planta Med. 2004 Sep;70(9):823-7
pubmed: 15503352
Med J Islam Repub Iran. 2019 Dec 27;33:154
pubmed: 32280660
Cochrane Database Syst Rev. 2020 Jul 16;7:CD008037
pubmed: 32671834
Int J Clin Pract. 2020 Jul;74(7):e13498
pubmed: 32159257
Evid Based Complement Alternat Med. 2012;2012:429320
pubmed: 22536283
J Periodontal Res. 2015 Jun;50(3):380-8
pubmed: 25203776
Gene. 2019 May 25;698:179-185
pubmed: 30844477
Clin Nutr. 2019 Apr;38(2):594-602
pubmed: 29661513
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
J Med Food. 2016 Aug;19(8):717-29
pubmed: 27533649
Mol Nutr Food Res. 2016 Dec;60(12):2576-2586
pubmed: 27487982
Genes Nutr. 2019 May 22;14:18
pubmed: 31143299
Phytother Res. 2012 Nov;26(11):1719-25
pubmed: 22407780

Auteurs

Jean-Guillaume Letarouilly (JG)

Department of Rheumatology, CHU Lille, Université de Lille, F-59000 Lille, France.

Pauline Sanchez (P)

Department of Rheumatology, CHU de Montpellier, Montpellier University, 34295 Montpellier, France.

Yann Nguyen (Y)

Department of Internal Medicine, Hôpital Beaujon, AP-HP Nord, Université de Paris, F-92100 Clichy, France.

Johanna Sigaux (J)

Department of Rheumatology, Hôpital Avicenne, AP-HP, INSERM U1125, Université Paris 13, F-93017 Bobigny, France.

Sébastien Czernichow (S)

Department of Nutrition, Specialized Obesity Center, Hôpital Européen Georges Pompidou, Université de Paris, AP-HP, F-75015 Paris, France.
Epidemiology and Biostatistics Sorbonne Paris City Center, UMR1153, Institut National de la Santé et de la Recherche Médicale, F-75004 Paris, France.

René-Marc Flipo (RM)

Department of Rheumatology, CHU Lille, Université de Lille, F-59000 Lille, France.

Jérémie Sellam (J)

DMU 3ID, Hôpital Saint Antoine, AP-HP, CRSA Inserm UMRS_938, Sorbonne Université, F-75012 Paris, France.

Claire Daïen (C)

Department of Rheumatology, CHU de Montpellier, Montpellier University, 34295 Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH